Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,624.70
(
-1.36%
)
US TECH 100
23,755.20
(
-1.56%
)
Dow Jones
46,225.15
(
-1.63%
)
Brent Oil
107.66
(
1.01%
)
Bitcoin
71,046.52
(
-0.27%
)
News Focus
News Focus
Post# of 257257
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ronpopeil

Send PM Follow Ignore
Followers 123
Posts 8886
Boards Moderated 0
Alias Born 10/05/2004

ronpopeil

Re: DewDiligence post# 120602

Thursday, 05/26/2011 3:46:53 PM

Thursday, May 26, 2011 3:46:53 PM

Post# of 257257
But the failure of the AIM-HIGH study no longer makes it the drug of choice. AMR-101, still shows more of a benefit when you compare the two with all things being equal. Had AIM-HIGH been successful, then AMR-101 could have been viewed as somewhat inferior. That is no longer the case imo which is why you are seeing a positive reaction in the stock price. I still believe AMRN's outcomes study will be successful

"Don't worry about the world coming to an end today. It's already tomorrow in Australia"

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now